Chester County News and Community Website
PLYMOUTH MEETING, PA — New research published in the November 2025 issue of the Journal of the National Comprehensive Cancer Network (JNCCN) finds that cancer clinics overwhelmingly view team-based supportive …
Study Reveals Patients Favor Human Support Over Tech in Cancer Care Models Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) unveiled compelling new data from its Phase 2 study of VP-315, a first-in-class oncolytic peptide immunotherapy, showing strong local immune activation …
New Cancer Data Hints at a Surgery-Free Future — Verrica’s VP-315 Shows Big Promise Read More
HARRISBURG, PA — A new report from the American Lung Association paints a mixed picture for Pennsylvania’s fight against lung cancer. While the state ranks among the best in the …
Pennsylvania Among Top States for Lung Cancer Survival, But Risks Remain High Read More
PLYMOUTH MEETING, PA — New research published online in JNCCN—Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much lower risk of …
Quitting Smoking After Cancer Diagnosis Tied to Sharply Lower Two-Year Mortality, Study Finds Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) last week added breast cancer treatment and genetic/familial high-risk assessment to its NCCN Guidelines Navigator™ platform, broadening access to digitized, …
NCCN Expands Digital Navigator With New Breast Cancer and Genetic Risk Resources Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced new funding to support quality improvement projects aimed at advancing breast cancer outcomes. The …
NCCN Oncology Research Program Announces New Funding for Breast Cancer Quality Initiatives Read More PLYMOUTH MEETING, PA — A new study published in the September 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms the effectiveness of a specialized tool for identifying …
Study Validates GO-PIMs Tool for Safer Cancer Care in Older Adults Read More PLYMOUTH MEETING, PA — New research published in the July 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network offers encouraging news for men diagnosed with nonmetastatic prostate cancer. …
Study Finds Most Prostate Cancer Patients Following NCCN Guidelines Live Long, Healthy Lives Read More
WILMINGTON, DE — The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab significantly improves progression-free survival (PFS) for patients with HER2-positive metastatic …
ENHERTU plus Pertuzumab Shows Significant Progress in First-Line Treatment for HER2-Positive Breast Cancer Read More WILMINGTON, DE — The Phase III MATTERHORN trial has delivered groundbreaking results, demonstrating that AstraZeneca’s IMFINZI® (durvalumab) combined with FLOT chemotherapy significantly improves outcomes for patients with resectable early-stage and …
MATTERHORN Trial Reveals Promising Results for Early Gastric Cancer Treatment Read More